Focus topics

WHO approves Sinopharm

The World Health Organization (WHO) has granted emergency approval to Chinese manufacturer Sinopharm’s Covid vaccine. “As a new vaccine in the pandemic response arsenal, it has the potential to increase access to vaccines,” said WHO Vice Chief Mariângela Simão. The organization now expects the manufacturer to contribute to the Covax joint vaccination campaign, she added. WHO inspectors visited the production facilities and found no shortcomings. They said the evaluation of studies testing the active ingredient showed it to be safe and effective. While Sinopharm’s product has a positive press, doubts surround the effectiveness of Sinovac’s rival product (China.Table reported). WHO approval for this is still pending. fin

Continue reading now

Get 30 days of free access to the Decision Brief to read these and more quality news every day.

Are you already a guest at the China.Table? Log in now


    Chinese Chamber of Commerce sees poor sentiment
    Tax incentive for real estate purchase
    China’s first mRNA vaccine receives approval – in Indonesia
    USA invests in Pacific island states